Use of Epidermal Growth Factor Receptor Mutation Analysis in Patients with Advanced Non-Small-Cell Lung Cancer to Determine Erlotinib Use as First-Line Therapy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.